Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single arm, "roll-in" study of esmolol infusion for patients with
septic shock with persistent tachycardia after adequate intravenous volume expansion. The
study will evaluate the adequacy and efficiency of study protocols for the anticipated, main
ECASSS study, which will have a separate entry in clinicaltrials.gov.